revised focus on inflammation
TRANSCRIPT
![Page 1: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/1.jpg)
Focus on Inflammation
(Relates to Chapter 13, “Inflammation and Wound
Healing,” in the textbook)
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 2: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/2.jpg)
2
Inflammatory Response
• Sequential response to cell injury– Neutralizes and dilutes inflammatory agent– Removes necrotic materials– Establishes an environment suitable for
healing and repair
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 3: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/3.jpg)
3
Inflammatory Response
• Mechanism of inflammation basically the same regardless of injuring agent
• Intensity of the response depends on– Extent and severity of injury– Reactive capacity of injured person
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 4: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/4.jpg)
4
Inflammatory Response
• Inflammatory response can be divided into: – Vascular response– Cellular response– Formation of exudate– Healing
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 5: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/5.jpg)
5
![Page 6: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/6.jpg)
6
Inflammatory Response Vascular Response
• After cell injury, arterioles in area briefly undergo transient vasoconstriction.
• After release of histamine and other chemicals by the injured cells, vessels dilate, resulting in hyperemia.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 7: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/7.jpg)
7
Inflammatory Response Vascular & Chemical Response
• Vasodilation chemical mediators – Endothelial cell retraction – Increased capillary permeability– Movement of fluid from capillaries into tissue
spaces
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 8: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/8.jpg)
8
Inflammatory Response Vascular Response
• Fluid in tissue spaces– Initially composed of serous fluid– Later contains plasma proteins, primarily
albumin• Proteins exert oncotic pressure that further draws
fluid from blood vessels.• Tissue becomes edematous.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 9: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/9.jpg)
9
Inflammatory Response Vascular Response
• As plasma protein fibrinogen leaves blood, it is activated to fibrin by products of the injured cells.
• Fibrin strengthens a blood clot formed by platelets.
• In tissue, clots trap bacteria to prevent spread.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 10: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/10.jpg)
10
Inflammatory Response Cellular Response
• Blood flow through capillaries in the area of inflammation slows as fluid is lost and viscosity increases.
• Neutrophils and monocytes move to the inner surface of the capillaries and then migrate through the capillary wall to the site of the injury.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 11: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/11.jpg)
11
Inflammatory Response Cellular Response
• Chemotaxis– Directional migration of WBCs along
concentration gradient of chemotactic factors– Mechanism for accumulating neutrophils and
monocytes at site of injury
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 12: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/12.jpg)
12
Inflammatory Response Cellular Response
• Neutrophils– First leukocytes to arrive at site of injury (6 to
12 hours) – Phagocytize bacteria, other foreign material,
and damaged cells – Short life span (24 to 48 hours)
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 13: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/13.jpg)
13
Inflammatory Response Cellular Response
• Neutrophils– Pus is composed of
• Dead neutrophils accumulated at the site of injury• Digested bacteria• Other cell debris
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 14: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/14.jpg)
14
Inflammatory Response Cellular Response
• Neutrophils– Bone marrow releases more neutrophils in
response to infection, resulting in elevated WBC.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 15: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/15.jpg)
15
Inflammatory Response Cellular Response
• Monocytes– Second type of phagocytic cells to migrate
to site of injury from circulating blood– Attracted to the site by chemotactic factors– Arrive within 3 to 7 days after the onset of
inflammation
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 16: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/16.jpg)
16
Inflammatory Response Cellular Response
• Monocytes– On entering tissue spaces, monocytes
transform into macrophages.– Assist in phagocytosis of inflammatory
debris– Macrophages have a long life span and can
multiply.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 17: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/17.jpg)
17
Inflammatory Response Cellular Response
• Macrophage– Important in cleaning the area before
healing can occur– May stay in damaged tissues for weeks– Cells may fuse to form a multinucleated
giant cell.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 18: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/18.jpg)
18
Inflammatory Response Cellular Response
• Lymphocytes – Arrive later at the site of injury– Primary roles of lymphocytes involve
• Cell-mediated immunity• Humoral immunity
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 19: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/19.jpg)
19
Inflammatory Response Cellular Response
• Exudate– Consists of fluid and leukocytes that move
from the circulation to the site of injury– Nature and quantity depend on the type and
severity of the injury and the tissues involved.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 20: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/20.jpg)
20
Inflammatory Response Clinical Manifestations
• Local response to inflammation– Redness– Heat– Pain– Swelling– Loss of function
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 21: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/21.jpg)
21
Inflammatory Response Clinical Manifestations
• Systemic response to inflammation– Increased WBC count with a shift to the
left– Malaise– Nausea and anorexia– Increased pulse and respiratory rate– Fever
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 22: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/22.jpg)
22
Inflammatory Response Clinical Manifestations
• Systemic response to inflammation– The causes of the systemic response are
poorly understood, but it is probably due to complement activation and the release of cytokines.
– Some of the cytokines are IL-1, IL-6, and tumor necrosis factor.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 23: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/23.jpg)
23
Inflammatory Response Clinical Manifestations
• Systemic response to inflammation – Fever
• Onset is triggered by release of cytokines.• Cytokines cause fever by initiating metabolic
changes in the temperature-regulating center.• Epinephrine released from the adrenal medulla
increases metabolic rate.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 24: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/24.jpg)
24
Fig. 13-3. Production of fever. When monocytes-macrophages are activated, they secrete cytokines such as interleukin-1 (IL-1), interleukin-6 (IL-6), and tumor necrosis factor (TNF), which reach the hypothalamic temperature-regulating center. These cytokines promote the synthesis and secretion of prostaglandin E2 (PGE2) in the anterior hypothalamus.
PGE2 increases the thermostatic set point, and the
autonomic nervous system is stimulated, resulting in shivering, muscle contraction, and peripheral vasoconstriction.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 25: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/25.jpg)
25Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 26: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/26.jpg)
26
Inflammatory Response Clinical Manifestations
• Systemic response to inflammation – Fever
• Patient then experiences chills and shivering.• Body is hot, yet person seeks warmth until the
circulating temperature reaches core body temperature.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 27: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/27.jpg)
27
Inflammatory Response Clinical Manifestations
• Systemic response to inflammation – Fever
• Beneficial aspects of fever include increased killing of microorganisms, increased phagocytosis, and increased proliferation of T lymphocytes.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 28: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/28.jpg)
28
Inflammatory Response Types of Inflammation
• Acute– Healing occurs in 2 to 3 weeks, usually
leaving no residual damage.– Neutrophils are the predominant cell type
at the site of inflammation.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 29: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/29.jpg)
29
Inflammatory Response Types of Inflammation
• Subacute– Has same features as acute inflammation
but persists longer
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 30: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/30.jpg)
30
Inflammatory Response Types of Inflammation
• Chronic– May last for years– Injurious agent persists or repeats injury to
site.– Predominant cell types involved are
lymphocytes and macrophages.– May result from changes in immune
system (e.g., autoimmune disease)
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 31: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/31.jpg)
31
Wound Healing
• The final phase of the inflammatory response– Healing
• Two major components--regeneration and repair.
• Regeneration– Replacement of lost cells and tissues with cells
of the same type– Ability to regenerate depends on cell type.– Constantly dividing cells that rapidly regenerate
• Skin, bone marrow, lymphoid organs, as well as mucous membrane cells of the urinary, reproductive, and GI tracts
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 32: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/32.jpg)
32
Wound Healing• Regeneration
– Replacement of lost cells and tissues with cells of the same type
• Stable cells such as liver, bone, kidney, and pancreas regenerate in response to injury.
• Permanent cells such as neurons and skeletal and cardiac muscle do not divide.
– Neurons are replaced by glial cells or stem cells.
– Skeletal and cardiac muscle will be repaired with scar tissue.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 33: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/33.jpg)
33
Wound Healing
• Repair– Healing as a result of lost cells being
replaced with connective tissue– More common than regeneration– More complex than regeneration– Occurs by primary, secondary, or tertiary
intention
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 34: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/34.jpg)
34Fig. 13-4. Types of wound healing. A, Primary intention. B, Secondary intention. C, Tertiary intention.
![Page 35: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/35.jpg)
35
Wound Healing
• Repair – Primary intention
• Includes three phases– Initial phase– Granulation phase– Maturation phase and scar contraction
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 36: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/36.jpg)
36
Wound Healing
• Repair– Initial phase
• Lasts 3 to 5 days• Edges of incision are aligned.• Blood fills the incision area, which forms
matrix for WBC formation.• Acute inflammatory reaction occurs.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 37: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/37.jpg)
37
Wound Healing
• Repair– Granulation phase
• Lasts 5 days to 3 weeks• Fibroblasts migrate to site.• Wound is pink and vascular.• Surface epithelium begins to regenerate.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 38: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/38.jpg)
38
Before and After Granulating
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Fig. 13-5. A, Wound clean but not granulating (note lack of red cobblestone appearance), suggesting heavy bacterial contamination or other impediments to wound healing. B, Same wound granulating after 1 week of topical antibiotic use (note healthy red cobblestone appearance).
![Page 39: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/39.jpg)
39
Wound Healing
• Repair Maturation phase and scar contraction
• Begins 7 days after injury and continues for several months/years
• Fibroblasts disappear as wound becomes stronger.
• Mature scar forms.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 40: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/40.jpg)
40
Wound Healing
• Repair Secondary intention
• Wounds that occur from trauma, ulceration, and infection have large amounts of exudate and wide, irregular wound margins with extensive tissue loss.
• Edges cannot be approximated.• Results in more debris, cells, and exudate
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 41: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/41.jpg)
41
Wound Healing
• Repair Tertiary intention
• Delayed primary intention due to delayed suturing of the wound
• Occurs when a contaminated wound is left open and sutured closed after the infection is controlled
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 42: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/42.jpg)
42
Wound Classification
• Classified by Cause
• Surgical or nonsurgical• Acute or chronic
Depth of tissue affected• Superficial, partial thickness, full thickness
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 43: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/43.jpg)
43
Wound Classification
• Classified by– Color
• Red• Yellow• Black• May have two or more colors
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 44: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/44.jpg)
44
Delay of Healing
• Nutritional deficiencies• Inadequate blood supply• Corticosteroid drugs• Infection • Smoking
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 45: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/45.jpg)
45
Delay of Healing
• Mechanical friction on wound• Advanced age• Obesity • Diabetes mellitus• Poor general health • Anemia
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 46: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/46.jpg)
46
Complications of Healing
• Adhesions• Contractures• Dehiscence• Evisceration• Excess granulation tissue• Fistula formation
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 47: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/47.jpg)
47
Complications of Healing
• Infection• Hemorrhage• Hypertrophic scars• Keloid formation
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 48: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/48.jpg)
48
Nursing Assessment
• Assess on admission and on a regular basis.
• Identify factors that may delay healing.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 49: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/49.jpg)
49
Fig. 13-9. Wound measurements are made in centimeters.
The first measurement is oriented from head to toe, the
second is from side to side, and the third is the depth (if
any). If there is any tunneling (when cotton-tipped
applicator is placed in wound,
there is movement) or undermining (when cotton-tipped
applicator is placed in wound, there is a “lip” around the
wound) this is charted in respect to a clock with 12
o’clock being toward the patient’s head. This wound
would be charted as a full-thickness, red wound, 7 cm × 5
cm × 3-cm, with a 3-cm tunnel at 7 o’clock and 2 cm
undermining from 3 o’clock to 5 o’clock.
![Page 50: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/50.jpg)
50
![Page 51: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/51.jpg)
51
Nursing Diagnoses
• Impaired skin integrity• Impaired tissue integrity• Risk for infection
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 52: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/52.jpg)
52
Nursing Implementation
• Care varies depending on– Causative agent– Degree of injury– Patient’s condition
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 53: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/53.jpg)
53
Nursing Implementation
• Purposes of wound management– Cleaning a wound– Treating infection– Protecting clean wound from trauma
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 54: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/54.jpg)
54
Nursing Implementation
• Sutures/fibrin sealant help closure.• Primary intention wounds may be
covered with dry dressing.• Drains may be inserted.• Topical antimicrobials/antibacterials
should be used with caution.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 55: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/55.jpg)
55
Nursing Implementation
• Secondary intention wound care depends on etiology and type of tissue in the wound.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 56: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/56.jpg)
56
Nursing Implementation
• Red Wounds Protect the wound Gentle cleaning, if needed
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 57: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/57.jpg)
57
Nursing Implementation
• Yellow wounds– Dressing that absorbs exudate and
cleanses the wound surface– Hydrocolloid dressings
• Black Wounds– Debridement of nonviable, eschar tissue
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 58: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/58.jpg)
58
Nursing Implementation
• Negative-pressure wound therapy– Suction removes drainage and speeds
healing.– Monitor serum protein levels, F&E
balance, and coagulation studies.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 59: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/59.jpg)
59
Nursing Implementation
• Hyperbaric O2 – Delivery of O2 at increased atmospheric
pressure– Allows O2 to diffuse into serum– Last 90 to 120 minutes, with 10 to 60
treatments
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 60: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/60.jpg)
60
Nursing Implementation
• Drug therapy Becaplermin (Regranex)
• Nutritional therapy Diet high in protein, carbohydrates, and
vitamins with moderate fat
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 61: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/61.jpg)
61
Nursing Implementation
• Infection prevention Do not touch recently injured area. Keep environment free from possibly
contaminated items. Antibiotics may be given
prophylactically.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 62: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/62.jpg)
62
Nursing Implementation
• Infection control Should cultures be done? Are they reliable? When would wound cultures be reliable? When would they be unreliable?
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 63: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/63.jpg)
63
Nursing Implementation
• Psychologic implications– Fear of scar or disfigurement– Drainage or odor concerns– Be aware of your facial expressions
while changing dressing.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 64: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/64.jpg)
64
Patient Teaching
• Teach signs and symptoms of infection.
• Note changes in wound color or amount of drainage.
• Provide medication teaching.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 65: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/65.jpg)
Focus on Pressure Ulcers
(Relates to Chapter 13, “Inflammation and Wound
Healing,” in the textbook)
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 66: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/66.jpg)
66
Pressure Ulcer
• A localized injury to the skin and/or underlying tissue due to pressure with or without shear/friction
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 67: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/67.jpg)
67
Incidence
• Most common sites Sacrum Heels
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 68: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/68.jpg)
68
Influencing Factors
• Amount of pressure (intensity)• Length of time pressure is exerted
(duration)• Ability of tissue to tolerate externally
applied pressure
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 69: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/69.jpg)
69
Contributing Factors
• Shearing force—Pressure exerted on the skin when it adheres to the bed and the skin layers slide in the direction of body movement
• Friction—Two surfaces rubbing against each other
• Excessive moisture
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 70: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/70.jpg)
70
Risk Factors
• Advanced age• Anemia• Contractures• Diabetes mellitus• Elevated body temperature
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 71: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/71.jpg)
71
Risk Factors
• Immobility• Impaired circulation• Incontinence • Low diastolic blood pressure
(<60 mm Hg)• Mental deterioration
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 72: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/72.jpg)
72
Risk Factors
• Neurologic disorders• Obesity • Pain• Prolonged surgery• Vascular disease
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 73: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/73.jpg)
73
Clinical Manifestations
• Ulcers are graded or staged according to deepest level of tissue damage:– Stage I (minor) to stage IV (severe)– Slough or eschar may have to be
removed for accurate staging of some ulcers.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 74: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/74.jpg)
74
Clinical Manifestations Stage I
• Intact skin with non-blanchable redness
• Possible indicators—Skin temperature, tissue consistency, pain
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 75: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/75.jpg)
75
Clinical Manifestations Stage I
• May appear with red, blue, or purple hues in darker skin tones
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 76: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/76.jpg)
76
Clinical Manifestations Stage II
• Partial-thickness loss of dermis • Shallow open ulcer with red pink
wound bed• Presents as an intact or ruptured
serum-filled blister
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 77: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/77.jpg)
77
Clinical Manifestations Stage III
• Full-thickness skin loss involving damage or necrosis of subcutaneous tissue that may extend down to, but not through, underlying fascia
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 78: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/78.jpg)
78
Clinical Manifestations Stage III
• Presents as a deep crater with possible undermining of adjacent tissue
• Depth of ulcer varies by anatomic location.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 79: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/79.jpg)
79
Clinical Manifestations Stage IV
• Full-thickness loss can extend to muscle, bone, or supporting structures.– Bone, tendon, or muscle may be visible
or palpable.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 80: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/80.jpg)
80
Clinical Manifestations Stage IV
• Undermining and tunneling may also occur.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 81: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/81.jpg)
81
Clinical Manifestations Infection
• Signs– Leukocytosis– Fever– Increased ulcer size, odor, or drainage– Necrotic tissue– Pain
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 82: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/82.jpg)
82
Clinical Manifestations Complications
• Most common—Recurrence• Cellulitis• Chronic infection• Osteomyelitis
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 83: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/83.jpg)
83
Assessment
• Assess pressure ulcer risk on admission and at periodic intervals based on care setting and patient’s condition.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 84: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/84.jpg)
84
Assessment Tools
• Use risk assessment tools such as the Braden scale for systematic skin inspection.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 85: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/85.jpg)
85
Assessment of Patients With Dark Skin
• Look for areas of skin darker (purplish, brownish, bluish) than surrounding skin.
• Use natural or halogen light for accurate assessment (fluorescent light casts a blue color that can skew results).
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 86: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/86.jpg)
86
Assessment of Patients With Dark Skin
• Assess skin temperature using your hand. An ulceration may feel warm initially,
then become cooler.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 87: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/87.jpg)
87
Assessment of Patients With Dark Skin
• Touch the skin to feel its consistency. Boggy or edematous tissue may indicate
a stage I pressure ulcer.• Ask about pain or an itchy sensation.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 88: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/88.jpg)
88
Planning
• Overall goals No deterioration Reduce contributing factors Not develop an infection Have healing Have no recurrence
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 89: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/89.jpg)
89
Prevention – Education
• Prevention is the best treatment.• Identify risk factors and implement
prevention strategies.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 90: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/90.jpg)
90
Prevention
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 91: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/91.jpg)
91
Prevention – Skin Care
• Remove excessive moisture.• Avoid massage over bony
prominences.• Turn every 1 or 2 hours (with care to
avoid shearing).• Use lift sheets.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 92: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/92.jpg)
92
Prevention – Skin Care
• Position with pillows or elbow and heel protectors.
• Use specialty beds.• Cleanse skin if incontinence occurs.
Use pads or briefs that are absorbent.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 93: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/93.jpg)
93
Prevention – Nutrition
• Caloric intake elevated to 30 to 35 cal/kg/day or 1.25 to 1.50 g protein/kg/day– Supplements, enteral, or parenteral
feedings may be necessary.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 94: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/94.jpg)
94
Treatment – Ulcer Care
• Document and describe size, stage, location, exudate, infection, pain, and tissue appearance.
• Keep ulcer bed moist.• Cleanse with nontoxic solutions.• Debride.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 95: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/95.jpg)
95
Treatment – Ulcer Care
• Use adhesive membrane, ointment, or wound dressing.
• Verify good nutrition.• Teach self-care and signs of
breakdown.• Initiate specialty services.
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
![Page 96: Revised focus on inflammation](https://reader036.vdocuments.site/reader036/viewer/2022062312/554b5a25b4c9051b458b4cd3/html5/thumbnails/96.jpg)
96
Operative Repair
• Skin grafts• Skin flaps• Musculocutaneous flaps• Free flaps
Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.